Cargando…

Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes

Introduction: The potentially unlimited number of cardiomyocyte (CMs) derived from human induced pluripotent stem cells (hiPSCs) in vitro facilitates high throughput applications like cell transplantation for myocardial repair, disease modelling, and cardiotoxicity testing during drug development. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yu, Su, Liping, Wei, Yuhua, Tan, Shihua, Hu, Zhenyu, Tao, Zhonghao, Kovalik, Jean-Paul, Soong, Tuck Wah, Zhang, Jianyi, Pu, Jun, Ye, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334833/
https://www.ncbi.nlm.nih.gov/pubmed/37441603
http://dx.doi.org/10.7150/thno.80801
_version_ 1785070930932793344
author Gao, Yu
Su, Liping
Wei, Yuhua
Tan, Shihua
Hu, Zhenyu
Tao, Zhonghao
Kovalik, Jean-Paul
Soong, Tuck Wah
Zhang, Jianyi
Pu, Jun
Ye, Lei
author_facet Gao, Yu
Su, Liping
Wei, Yuhua
Tan, Shihua
Hu, Zhenyu
Tao, Zhonghao
Kovalik, Jean-Paul
Soong, Tuck Wah
Zhang, Jianyi
Pu, Jun
Ye, Lei
author_sort Gao, Yu
collection PubMed
description Introduction: The potentially unlimited number of cardiomyocyte (CMs) derived from human induced pluripotent stem cells (hiPSCs) in vitro facilitates high throughput applications like cell transplantation for myocardial repair, disease modelling, and cardiotoxicity testing during drug development. Despite promising progress in these areas, a major disadvantage that limits the use of hiPSC derived CMs (hiPSC-CMs) is their immaturity. Methods: Three hiPSC lines (PCBC-hiPSC, DP3-hiPSCs, and MLC2v-mEGFP hiPSC) were differentiated into CMs (PCBC-CMs, DP3-CMs, and MLC2v-CMs, respectively) with or without retinoic acid (RA). hiPSC-CMs were either maintained up to day 30 of contraction (D30C), or D60C, or purified using lactate acid and used for experiments. Purified hiPSC-CMs were cultured in basal maturation medium (BMM) or BMM supplemented with ascorbic acid (AA) for 14 days. The AA treated and non-treated hiPSC-CMs were characterized for sarcomeric proteins (MLC2v, TNNI3, and MYH7), ion channel proteins (Kir2.1, Nav1.5, Cav1.2, SERCA2a, and RyR), mitochondrial membrane potential, metabolomics, and action potential. Bobcat339, a selective and potent inhibitor of DNA demethylation, was used to determine whether AA promoted hiPSC-CM maturation through modulating DNA demethylation. Results: AA significantly increased MLC2v expression in PCBC-CMs, DP3-CMs, MLC2v-CMs, and RA induced atrial-like PCBC-CMs. AA treatment significantly increased mitochondrial mass, membrane potential, and amino acid and fatty acid metabolism in PCBC-CMs. Patch clamp studies showed that AA treatment induced PCBC-CMs and DP3-CMs adaptation to a ventricular-like phenotype. Bobcat339 inhibited MLC2v protein expression in AA treated PCBC-CMs and DP3-CMs. DNA demethylation inhibition was also associated with reduced TET1 and TET2 protein expressions and reduced accumulation of the oxidative product, 5 hmC, in both PCBC-CMs and DP3-CMs, in the presence of AA. Conclusions: Ascorbic acid induced MLC2v protein expression and promoted ventricular-like CM subtype in hiPSC-CMs. The effect of AA on hiPSC-CM was attenuated with inhibition of TET1/TET2 mediated DNA demethylation.
format Online
Article
Text
id pubmed-10334833
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-103348332023-07-12 Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes Gao, Yu Su, Liping Wei, Yuhua Tan, Shihua Hu, Zhenyu Tao, Zhonghao Kovalik, Jean-Paul Soong, Tuck Wah Zhang, Jianyi Pu, Jun Ye, Lei Theranostics Research Paper Introduction: The potentially unlimited number of cardiomyocyte (CMs) derived from human induced pluripotent stem cells (hiPSCs) in vitro facilitates high throughput applications like cell transplantation for myocardial repair, disease modelling, and cardiotoxicity testing during drug development. Despite promising progress in these areas, a major disadvantage that limits the use of hiPSC derived CMs (hiPSC-CMs) is their immaturity. Methods: Three hiPSC lines (PCBC-hiPSC, DP3-hiPSCs, and MLC2v-mEGFP hiPSC) were differentiated into CMs (PCBC-CMs, DP3-CMs, and MLC2v-CMs, respectively) with or without retinoic acid (RA). hiPSC-CMs were either maintained up to day 30 of contraction (D30C), or D60C, or purified using lactate acid and used for experiments. Purified hiPSC-CMs were cultured in basal maturation medium (BMM) or BMM supplemented with ascorbic acid (AA) for 14 days. The AA treated and non-treated hiPSC-CMs were characterized for sarcomeric proteins (MLC2v, TNNI3, and MYH7), ion channel proteins (Kir2.1, Nav1.5, Cav1.2, SERCA2a, and RyR), mitochondrial membrane potential, metabolomics, and action potential. Bobcat339, a selective and potent inhibitor of DNA demethylation, was used to determine whether AA promoted hiPSC-CM maturation through modulating DNA demethylation. Results: AA significantly increased MLC2v expression in PCBC-CMs, DP3-CMs, MLC2v-CMs, and RA induced atrial-like PCBC-CMs. AA treatment significantly increased mitochondrial mass, membrane potential, and amino acid and fatty acid metabolism in PCBC-CMs. Patch clamp studies showed that AA treatment induced PCBC-CMs and DP3-CMs adaptation to a ventricular-like phenotype. Bobcat339 inhibited MLC2v protein expression in AA treated PCBC-CMs and DP3-CMs. DNA demethylation inhibition was also associated with reduced TET1 and TET2 protein expressions and reduced accumulation of the oxidative product, 5 hmC, in both PCBC-CMs and DP3-CMs, in the presence of AA. Conclusions: Ascorbic acid induced MLC2v protein expression and promoted ventricular-like CM subtype in hiPSC-CMs. The effect of AA on hiPSC-CM was attenuated with inhibition of TET1/TET2 mediated DNA demethylation. Ivyspring International Publisher 2023-07-03 /pmc/articles/PMC10334833/ /pubmed/37441603 http://dx.doi.org/10.7150/thno.80801 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Gao, Yu
Su, Liping
Wei, Yuhua
Tan, Shihua
Hu, Zhenyu
Tao, Zhonghao
Kovalik, Jean-Paul
Soong, Tuck Wah
Zhang, Jianyi
Pu, Jun
Ye, Lei
Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
title Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
title_full Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
title_fullStr Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
title_full_unstemmed Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
title_short Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
title_sort ascorbic acid induces mlc2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334833/
https://www.ncbi.nlm.nih.gov/pubmed/37441603
http://dx.doi.org/10.7150/thno.80801
work_keys_str_mv AT gaoyu ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT suliping ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT weiyuhua ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT tanshihua ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT huzhenyu ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT taozhonghao ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT kovalikjeanpaul ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT soongtuckwah ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT zhangjianyi ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT pujun ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes
AT yelei ascorbicacidinducesmlc2vproteinexpressionandpromotesventricularlikecardiomyocytesubtypeinhumaninducedpluripotentstemcellsderivedcardiomyocytes